STEP TEENS: Semaglutide 'Gives Hope' to Adolescents With Obesity

The so-called 'gamechanger' obesity injection, semaglutide, is trialed in teenagers with obesity and comes up trumps.

Related Keywords

Austria ,United States ,North Carolina ,Salzburg ,Duke University ,American ,Daniel Weghuber ,Sarahc Armstrong ,Silva Arslanian ,Aarons Kelly ,Claudiak Fox ,Paracelsus Medical University ,University Of Pittsburgh School Medicine ,Committee For The American Academy Of Pediatrics ,Duke Children Healthy Lifestyles Program ,University Of Minnesota Medical School ,University Of Pittsburgh ,University Of Minnesota ,Department Of Pediatrics ,New England Journal ,Medscape Medical ,Endowed Chair ,Pittsburgh School ,Pediatric Obesity Medicine ,Minnesota Medical ,American Board ,Obesity Medicine ,Duke Children ,Healthy Lifestyles Program ,Executive Committee ,American Academy ,With Obesity ,Childhood Obesity ,Adolescent Medicine ,Obesity ,Bese ,Glp 1 Receptor Agonists ,Glucagon Like Peptide 1 Receptor Agonists ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Body Mass Index Bmi ,Incretin Hormones ,Incretins ,Clinical Guidelines ,Guidelines ,Quality Of Life ,Pol ,Ealth Related Quality Of Life ,Rqol ,Weight Loss ,Weight Management ,Chronic ,